Business Context and Reporting Period
Company: Akers Biosciences, Inc. (Ticker: AKER)
Filing Type: Form 8-K (Current Report)
Date of Report: January 17, 2020
Reporting Period: Single event date (January 17, 2020)
Context: The filing discloses a proposed settlement regarding two shareholder derivative actions: Watts v. Gormally, et al. and Chan v. Gormally, et al.
Key Financial Metrics
This filing is a regulatory disclosure regarding legal proceedings and does not contain financial performance data. The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
The material change disclosed is the initiation of a settlement process for pending shareholder derivative litigation. No financial or operational changes relative to a prior comparable period are reported in this document.
Guidance, Outlook, and Risks
- Settlement Status: The Company has furnished a Notice of Settlement to current stockholders. The settlement is proposed and subject to conditions.
- Forward-Looking Statements: The filing contains forward-looking statements regarding the Proposed Settlement. Management warns that actual results could differ materially due to risks, including the failure to satisfy conditions necessary to make the settlement effective.
- Legal Contingencies: The filing references two active derivative actions in the District of New Jersey (D.N.J.).
- Information Source: Additional details on settlement terms and the hearing are available in Exhibit 99.1 and on the Company's website, though website content is not incorporated by reference.
Investor Verification Checklist
- Verify the specific terms and financial implications of the Proposed Settlement in Exhibit 99.1 (Notice of Settlement).
- Confirm the date and outcome of the related court hearing for the derivative actions.
- Assess the potential impact of the settlement on the Company's cash reserves and ongoing operations.
- Review the Company's website for updates on the settlement status, noting that such information is not incorporated into this filing.